Innovative BioTherapies (IBT) is a small biotechnology company located in Ann Arbor, MI, focused on developing medical devices to solve unmet medical needs. Our company has a talented and dedicated R&D team, which has patented several novel devices including the Selective Cytopheretic Device (SCD) currently in clinical use to treat inflammatory disease conditions including Acute Kidney Injury (AKI), Acute Respiratory Distress Syndrome (ARDS) and Multiple Organ Dysfunction (MOD) caused by various etiologies ranging from sepsis to COVID-19.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 650 Avis Dr,
- Industry
- Medical Device
- Website
- http://www.innbio.com
- HQ
- Ann Arbor, Michigan
Innovative Biotherapies (Ibt) Questions
Innovative Biotherapies (Ibt)'s website is http://www.innbio.com
Innovative Biotherapies (Ibt)'s LinkedIn profile is https://www.linkedin.com/company/innovativebiotherapies
Innovative Biotherapies (Ibt) has
4 employees.
View email and phone details for 4
employees at Innovative Biotherapies (Ibt).
Innovative Biotherapies (Ibt)'s industry is
Medical Device
Innovative Biotherapies (Ibt)'s top competitors are
Innovative Research,
Iontox,
Seraph Biosciences, Inc,
Rubicon Genomics,
Bia Clinical Group,
Takara Bio Usa, Inc.,
Amador Bioscience Ltd,
Celsee, Inc.,
Seastar Medical,
Circularis Biotechnologies.
Innovative Biotherapies (Ibt)'s categories are Medical Device
Innovative Biotherapies (Ibt)'s founding year is 2003
